Welcome to our dedicated page for Essent Group Ltd. SEC filings (Ticker: ESNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Essent Group Ltd. filings document a Bermuda mortgage insurer with common shares listed on the New York Stock Exchange under ESNT. Its 8-K reports furnish operating results and financial condition updates, including earnings releases that discuss mortgage insurance activity, dividends, investment income and capital management.
Proxy filings cover annual general meeting matters such as director elections, auditor ratification, executive compensation votes and board governance. The filing record also identifies the company’s registered common shares, par value, exchange listing and related exhibit disclosures.
Essent Group Ltd. (ESNT) – Form 4 Insider Transaction
On 06/23/2025, Mary Lourdes Gibbons, Essent’s SVP & Chief Legal Officer, sold 1,999 common shares of ESNT at $60.00 per share. Following the disposition, Gibbons still directly owns 251,023 shares. No derivative transactions were reported, and no Rule 10b5-1 plan was indicated. The filing was signed on 06/25/2025 by attorney-in-fact David B. Weinstock.
The sale represents less than 1% of the insider’s reported holdings, suggesting a routine portfolio move rather than a material change in insider ownership.
Essent Group Ltd. (ESNT) – Form 4 insider transaction
On 06/16/2025, Chief Financial Officer David B. Weinstock reported the sale of 2,500 common shares of Essent Group Ltd. at a weighted-average price of $58.79 (individual trades ranged between $58.68 and $59.04). Following the transaction, the executive directly owns 27,365 shares.
The filing confirms the transaction code “S,” indicating an open-market sale rather than the exercise of a derivative security or a 10b5-1 planned trade (the related checkbox is blank). Based on the disclosed figures, Mr. Weinstock’s ownership declined by roughly 8.4%, from an estimated 29,865 shares before the sale to the current 27,365 shares.
No derivative transactions, option exercises, or additional purchases were reported, and the filing does not reference any Rule 10b5-1 trading plan. The Form 4 was signed on 06/18/2025.